ESC 365 - Levosimendan versus dobutamine in cardiogenic shock. A real alternative?

ACVC Premium Access

Levosimendan versus dobutamine in cardiogenic shock. A real alternative?

Session: Poster Session 2 - Acute Heart Failure: Pharmacotherapy

Topic: Pharmacotherapy

Speaker: Doctor M. Corbi Pascual (Albacete, ES)

Event: Acute Cardiovascular Care 2019

Congress Presentation

Add to my library

About the speaker

Doctor Miguel Jose Corbi Pascual

University Hospital Complex of Albacete, Albacete (Spain)

0 follower

3 more presentations in this session

Efficacy of tolvaptan in treating patients with heart failure with the preserved ejection fraction

Speaker: Doctor Y. Suzuki (Nagakute-cho, JP)

Prognostic impact of nitrate use in acute heart failure

Speaker: Mr J. Lopes (Coimbra, PT)

The impact of spironolactone in heart failure with mid-range ejection fraction: a future therapeutic tool?

Speaker: Doctor M. Pires (Viseu, PT)

Access the full session

Poster Session 2 - Acute Heart Failure: Pharmacotherapy

Speakers: Doctor M. Corbi Pascual, Doctor Y. Suzuki, Mr J. Lopes, Doctor M. Pires

About the event

Acute Cardiovascular Care 2019

2 March - 4 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources